TSX.V: PURE AUGUST 2018 - Pure Global Cannabis Inc.
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
TSX.V: PURE AUGUST 2018
2 | TSX.V: PURE OTC: PRCNF
Disclaimer
Certain information contained herein may constitute “forward-looking information” factors that could cause actual results to differ materially from those contained in
under Canadian securities legislation. Generally, forward-looking information can be forward-looking statements or forward-looking information, there may be other factors
identified by the use of forward-looking terminology such as “expects” or “it is expected”, that cause results not to be as anticipated, estimated or intended. There can be no
or variations of such words and phrases or statements that certain actions, events or assurance that such statements will prove to be accurate, as actual results and future
Matthew Brodeur on Unsplash
results “will” occur. Forward-looking statements are based on the opinions and estimates events could differ materially from those anticipated in such statements. Accordingly,
of management as of the date such statements are made and they are subject to known readers should not place undue reliance on forward-looking statements and forward-
and unknown risks, uncertainties and other factors that may cause the actual results, looking information. The Company does not undertake to update any forward-looking
level of activity, performance or achievements of the Company to be materially different statements or forward-looking information that is incorporated by reference herein,
from those expressed or implied by such forward-looking statements or forward-looking except as required by applicable securities laws. This version of the company’s forward-
information. Although management of the Company has attempted to identify important looking statements will supercede any previously dated versions.3 | TSX.V: PURE OTC: PRCNF
World Cannabis “Based on a review of third-party market research reports, one
could estimate the global cannabis market to be approximately $25
Landscape.
billion-$30 billion in 2020.”
— CIBC, Cannabis: Almost Showtime — A Legitimate Industry With Potentially $1
Billion Of EBITDA, May 7, 2018
Medical
Medical & Recreational4 | TSX.V: PURE OTC: PRCNF
Canadian Leadership
With A Pure World View.
Comprised of pharma-industry experts, our team is dedicated to producing the highest quality - consistently
Pure - cannabis products. Our vision is to become the most trusted global brand, while harnessing the
therapeutic properties of cannabis in tomorrow’s medicines and consumer products.
Our strategy is to deploy leading-edge pharmaceutical technologies to create world-class, innovative
cannabis products that strengthen our position in both the medical and adult-use markets.5 | TSX.V::PURE OTC: PRCNF
Why Own
Pure Global?
Attractive Relative Exceptional Leadership Intellectual Property Fully-Funded Milestones
Valuation Team & Capital Markets Advantage
Support
TSX.V: PURE Seasoned pharma-industry experts Canada’s first multi-ponic cannabis Licences:
and world-renowned specialist in farm; patent-pending system
OTC: PRCNF Dec 2017: ACMPR Cultivation Licence
plant genetics and commercial scale produces several fold greater yields
Price: $0.33/share indoor and greenhouse horticulture over traditional while reducing cost Q3 2018: ACMPR Sales Licence (est.)
and eliminating pesticide/herbicide
Market Cap: $48M Facility:
Leading team of capital markets use
Issued & outstanding: 147.8M advisors has been involved in Phase 1: Q3 2018
raising over $600M for cannabis High-efficiency vertical farm Packaging, QA, storage and
Warrants & options: 34.6M and other high-growth companies maximizes utility of square footage supercritical CO2 extraction
in recent years; $15M raised for
Fully diluted: 182.4M Phase 2: Q4 2018
Pure to-date Purpose-built indoor facility will
meet GMP standards for global 18,000 sq. ft. facility producing 4,000
Average market cap of Cdn LP: $720M Global reach of industry experts, exports kg/yr of premium-quality flower
thought leaders, influencers, and
Median market cap of Cdn LP: $161M Phase 3: Q1 2019
strategic investors Adapting pharmaceutical
23,000 sq. ft. facility at adjacent ad-
technologies to develop unique
dress doubles total production capaci-
cannabis formulations for specific
use cases ty to 8,000 kg/yr
41,000 sq. ft. of total capacity in 20196 | TSX.V::PURE OTC: PRCNF
Milestones.
6000 BC China 1937 USA January 2016 June 2018 Oct 17, 2018
Cannabis seeds Possession of Security clearance Passing of Bill Legalization of
used for food cannabis is illegal C-45 adult-use Cannabis
in Canada
4000 BC China March 2014 June 2016 Q3 2018
Hemp incorporated Introduction of Marihuana Facility Phase 1 Expected
into textiles for Medical Purposes Commencement ACMPR Sales
Regulations (MMPR) Licence
PAST PRESENT FUTURE*
100 BC China
Psychotropic properties Q4 2018 Q1 2019
of cannabis noted in March 2014 Facility Phase 2 Facility Phase 3
Pen Ts’ao Ching PureSinse Incorporated Construction Construction
1700s
Hashish becomes a major December 2017
trade item between Central November 2014 ACMPR Cultivation
Asia and South Asia HC Application Licence
*Estimated Dates7 | TSX.V::PURE OTC: PRCNF
Flagship Facility.
The PureSinse facility sits in the heart of an industrial district in Brampton, Ontario, strategically
located only 10 minutes from the Toronto International Airport and 35 minutes to the downtown core.
Q3 2018 • Level 9 Vault Stores $32M in Product
PHASE 1*
• Extraction, QA & Microbiology Labs
• Order Processing & Packaging
• Shipping & Receiving
• Security, IT & Admin
Q4 2018 • Automated Controlled Growth Environments
PHASE 2*
• Multiple Tiers of Vertical Farming Cultivation
18,000 SQ. FT. • Tissue Culture, Cloning, & Mother Rooms
4,000 kg/yr •
•
Drying, Trimming & Processing
Extractions Packaging & Processing
Q1 2019 • Vertical Farming Cultivation
PHASE 3*
• Cloning, Vegetation & Flowering
41,000 SQ. FT. • Extraction & Distillation Lab
8,000 kg/yr
• Order Processing & Packaging
• Advanced Analytical R&D Laboratory
Continuously evaluating opportunities for additional expansion, both at our current facility and beyond.
*Estimated Dates8 | TSX.V: PURE OTC: PRCNF
Canada’s First Multi-Ponic
Cannabis Farm.
Pure’s VP Production is an award-winning plant geneticist and horticulture specialist,
with extensive experience growing hundreds of plant varieties and managing
3x Yield
of similar
footprint
commercial-scale grow operations across the globe.
Leveraging this experience, Pure has designed a unique multi-ponic* growing system
that combines the best-practices of hydroponics, aquaponics, and aeroponics, with
world-class commercial agriculture methodologies. This automated system is capable
of growing more plants in less time, without the use of herbicides or pesticides.
*Patent pending
The Root Best More Canopy, Individual
Is The Heart: In Class: Less Space: Attention:
Closed-loop systems allow us to Targeted spectrum LED lighting Vertical farming enables us to Utilizing controlled-growth
tailor the biochemistry and nutrients systems ensure the plant expends grow multiple tiers of canopy, environments, every plant is
to deliver exactly what the roots need all its energy on growing the purest, exponentially increasing potential meticulously cared for and monitored
at every stage for optimal growth. most abundant high-grade flower. yield from the same square throughout its life cycle to ensure
footage. optimal growth.9 | TSX.V::PURE OTC: PRCNF
A Quicker Path To Revenue
With Concentrates.
The foundation for all medical applications and high-margin
recreational products is cannabis concentrates.
Our Phase 1 facilities are equipped with GMP standard clean
rooms to produce innovative and proprietary extraction
formulations with low-cost wholesale flower.
Dried Cannabis Oils Soft Gels & Seedlings & Vape Pen
Flower Capsules Clones Cartridges
Canadian Oil Sales International Oil Exports
30% 300% Topicals Sublingual
Strip/Spray
Transdermal
Patch
Edibles &
Beverages
Wellness
Products
GROWTH INCREASE
Quarter over quarter From 2016 – 201710 | TSX.V: PURE OTC: PRCNF
Pure Patient
Driven Solutions.
We are pharmacists first. That’s why our core focus on purity
puts patient wellbeing at the centre of everything we do.
“Over the long term, we believe consumers will develop a better understanding of cannabis and be able to
segment products based on perceived quality. As a result, although a strong brand may encourage initial trial,
there must be perceived product quality and a consistent user experience to validate the brand and generate
repeat purchases.”
— BMO, Canada Leads the Global Cannabis Paradigm Shift, May 2018
1. 2. 3. 4.
Quality Exceptional Clinic Innovative
First Service Partnerships Marketing
Our multi-ponic vertical Continuous feedback loops Utilizing a proven formula A bold, multi-faceted brand
farm is rooted in world-class curate a deep understanding of for rapid patient acquisition, strategy creates immediate
commercial horticulture and our patients’ needs, and ensure our alliances with clinics and demand and opens up new
delivers uncompromising satisfaction and engagement referring physicians grow market patient acquisition touch-
quality and consistency. during every interaction. share for sustained success. points across growing
customer verticals.11 | TSX.V: PURE OTC: PRCNF
Management.
Malay Panchal, RPh, BScPhm Bhupender Gosain, CA Vishwas Sawant, MBA Nader Gheshlaghi, PhD
Founder & CEO, Board Member Chief Financial Officer General Manager VP, Production
A seasoned serial-entrepreneur with 30+ years experience in tax and 30 years of global experience in With a PhD in Plant Genetics &
20+ years experience in pharma B2B business advisory services in a variety heavy engineering manufacturing, Pathology, Nader has managed
technology, retail and mail-order of sectors including technology, life agribusiness, retail and IT. Former large-scale grow operations for
pharmacy, pharma branding and sciences, biotechnology, natural CEO, Farmers Co-op, India, 55M CAD hundreds of plant varieties around the
clinical trials. resources and pharma. revenue, 1200 employees. world.
Trupti P. Smit, LLB Rachel Colic Michael Lavergne Stephen Pynn
Director of Corporate and Legal VP, Brand Strategy & PR Director of Supply Chain VP Corporate Development
Affairs 15+ years experience in B2C and Hands-on sustainable supply chain and Significant experience in Capital
15+ years experience in intellectual B2B marketing communications operations professional with 20 years of Markets and Corporate Finance with a
property, corporate law, international with an extensive portfolio of multinational experience in fast-moving focus primarily on the cannabis sector’s
tax and corporate governance. fully integrated and successfully consumer goods (FMCG) / retail. financings and public offerings.
executed brand experiences.12 | TSX.V: PURE OTC: PRCNF
Board.
Malay Panchal, RPh, BScPhm Dr. Chandra Panchal, PhD Jane Pagel, MSc
Founder & CEO, Board Member Chairman Board Member
A seasoned serial-entrepreneur with Distinguished resume includes Director Retired executive with extensive
20+ years experience in pharma B2B for MaRS Innovation, senior scientist at experience, previously held positions as
technology, retail and mail-order John Labatt Ltd., and Chairman, President the President & CEO of the Ontario Clean
pharmacy, pharma branding and clinical and CEO at Procyon Biopharma Water Agency, and Director of Research
trials. Inc. & Technology at the Ministry of the
Environment.
Brian O’Neill, BSc, LLB Albert Beraldo, CPA, CA
Board Member Board Member
Nearly a decade in the practice More than 30 years’ experience in
of law at a leading national law various senior leadership roles within
firm, focused on M&A, corporate the pharmaceutical and biotechnology
reorganizations, corporate finance, industry, including Founder & CEO of
intellectual property, and commercial Alveda Pharmaceuticals Inc.
transactions.13 | TSX.V: PURE OTC: PRCNF Capital Markets Advisors. Jeffrey Zicherman Aaron Salz Eventus Capital Stoic Advisory Founder and CEO of a leading investment bank based in Toronto, Canada. Founder and CEO of a pioneering financial advisory firm focused on the Jeff has led or been directly involved in raising over $600 million in cannabis industry. Aaron has been directly involved in over $2 billion of equity for numerous public companies in recent years, including several M&A transactions and advised numerous CEOs and boards of directors in cannabis mandates. the sector. Industry Advisors. Trina Fraser Paul Sparkes Jim Youmans Dr. Matthew D. Burnstein B.Sc., M.D. Brazeau Seller Law Norris Point Capital Rx Samples Solutions USA Appletree Medical Group The foremost cannabis policy and Former senior aid to two Premiers, 40+ years experience in corporate Over 35 years of practice as a family regulatory expert in the industry, Director of Operations to Prime pharma, with senior positions at every physician. Certified Medical Review Trina is actively working with Pure Minister Chretien, former LCBO major company of note; advising on Officer, trained to develop workplace Global on regulatory affairs and board member; advising on market medical branding, sales and market drug and alcohol programs, as well as licensing applications. penetration strategies. strategies. interpret drug tests.
14 | TSX.V::PURE OTC: PRCNF
Pure Capital
Structure.
TSX.V: RSL (to be changed to
$0.33/share
TSX.V: PURE upon RTO completion)
Market cap $48M
Issued and outstanding 147.8M
Warrants and options 34.6M
Fully diluted 182.4M
Cash $11.2M
Debt $015 | TSX.V::PURE OTC: PRCNF
Public Licensed Producer Universe.
8000
4000 PUBLIC LP MARKET CAPITALIZATION ($MM)
39 PUBLICLY TRADED LPs 2000
1000
MARKET CAP RANGE:
$32M - $7.5B
850
AVERAGE MARKET 650
CAP: $720M
450
MEDIAN MARKET CAP:
250
$161M
50
CHV
XLY
TLRY
BBT
HVT
TRST
VIR
EVE
BLIS
PURE
NDVA
RQB
JWCA
NRTH
BE
GTEC
ALEF
NINE
THC
SPR
EMC
GENE
WMD
HIKU
HUGE
MARI
ABCN
VFF
HIP
TER
FIRE
EMH
OGI
HEXO
TGOD
CRON
APH
LEAF
ACB
WEED
Source: Company Reports, Thomson Eikon, SEDAR, Analyst Estimates, Basic Market Capitalizations as of July 3, 2018Invest. Relax. Repeat. pureglobal.com | invest@pureglobal.com
You can also read
